Remodulin 50 mg/20mL
treprostinil · INJECTION, SOLUTION · United Therapeutics Corporation
No Recall History
Plain English
Remodulin is a injection, solution containing treprostinil at 50 mg/20mL, taken intravenous. Manufactured by United Therapeutics Corporation.
Key Facts
- Brand Name
- Remodulin
- Generic Name
- treprostinil
- NDC Code (Product)
66302-102- Manufacturer
- United Therapeutics Corporation
- Strength
- 50 mg/20mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- NDA021272
- Drug Class
- Prostacycline Vasodilator [EPC]
- Marketing Start
- 05/22/2002
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
dyspnoea9,577 reports
headache6,871 reports
diarrhoea6,651 reports
nausea5,979 reports
infusion site pain5,587 reports
death5,150 reports
fatigue3,882 reports
dizziness3,675 reports
vomiting3,306 reports
infusion site erythema3,221 reports
Frequently Asked Questions
What is Remodulin used for?
Remodulin contains treprostinil. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Remodulin a controlled substance?
Remodulin is not classified as a controlled substance by the DEA.
What is the generic name for Remodulin?
The generic name for Remodulin is treprostinil. There are 12 other brand versions of treprostinil.
What is the NDC code for Remodulin 50 mg/20mL?
The NDC (National Drug Code) for Remodulin 50 mg/20mL is 66302-102, listed by United Therapeutics Corporation.